229 related articles for article (PubMed ID: 28685972)
1. KIR2DS5 allotypes that recognize the C2 epitope of HLA-C are common among Africans and absent from Europeans.
Blokhuis JH; Hilton HG; Guethlein LA; Norman PJ; Nemat-Gorgani N; Nakimuli A; Chazara O; Moffett A; Parham P
Immun Inflamm Dis; 2017 Dec; 5(4):461-468. PubMed ID: 28685972
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
3. Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I.
Moesta AK; Graef T; Abi-Rached L; Older Aguilar AM; Guethlein LA; Parham P
J Immunol; 2010 Oct; 185(7):4233-7. PubMed ID: 20802150
[TBL] [Abstract][Full Text] [Related]
4. Novel Approach to Cell Surface Discrimination Between KIR2DL1 Subtypes and KIR2DS1 Identifies Hierarchies in NK Repertoire, Education, and Tolerance.
Le Luduec JB; Boudreau JE; Freiberg JC; Hsu KC
Front Immunol; 2019; 10():734. PubMed ID: 31024561
[TBL] [Abstract][Full Text] [Related]
5. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
Hilton HG; Vago L; Older Aguilar AM; Moesta AK; Graef T; Abi-Rached L; Norman PJ; Guethlein LA; Fleischhauer K; Parham P
J Immunol; 2012 Aug; 189(3):1418-30. PubMed ID: 22772445
[TBL] [Abstract][Full Text] [Related]
6. Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-C.
Hilton HG; Blokhuis JH; Guethlein LA; Norman PJ; Parham P
J Immunol; 2017 Mar; 198(5):1961-1973. PubMed ID: 28122963
[No Abstract] [Full Text] [Related]
7. A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia.
Nakimuli A; Chazara O; Hiby SE; Farrell L; Tukwasibwe S; Jayaraman J; Traherne JA; Trowsdale J; Colucci F; Lougee E; Vaughan RW; Elliott AM; Byamugisha J; Kaleebu P; Mirembe F; Nemat-Gorgani N; Parham P; Norman PJ; Moffett A
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):845-50. PubMed ID: 25561558
[TBL] [Abstract][Full Text] [Related]
8. Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopes.
Moesta AK; Abi-Rached L; Norman PJ; Parham P
J Immunol; 2009 Mar; 182(6):3628-37. PubMed ID: 19265141
[TBL] [Abstract][Full Text] [Related]
9. Characterization of KIR
Meazza R; Falco M; Canevali P; Loiacono F; Colomar-Carando N; Muntasell A; Rea A; Mingari MC; Locatelli F; Moretta L; Lopez-Botet M; Pende D
HLA; 2022 Aug; 100(2):119-132. PubMed ID: 35439359
[TBL] [Abstract][Full Text] [Related]
10. Association of KIR Genes and MHC Class I Ligands with Atopic Dermatitis.
Margolis DJ; Mitra N; Hoffstad OJ; Kim BS; Monos DS; Phillips EJ
J Immunol; 2021 Sep; 207(6):1522-1529. PubMed ID: 34408014
[TBL] [Abstract][Full Text] [Related]
11. Lack of association of KIR2DL1-R
Loubser S; Da Costa Dias B; Shalekoff S; Gentle NL; Tiemessen CT
Hum Immunol; 2021 Aug; 82(8):600-607. PubMed ID: 33906789
[TBL] [Abstract][Full Text] [Related]
12. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
Winter CC; Gumperz JE; Parham P; Long EO; Wagtmann N
J Immunol; 1998 Jul; 161(2):571-7. PubMed ID: 9670929
[TBL] [Abstract][Full Text] [Related]
13. Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.
Vineretsky KA; Karagas MR; Christensen BC; Kuriger-Laber JK; Perry AE; Storm CA; Nelson HH
Cancer Res; 2016 Jan; 76(2):370-6. PubMed ID: 26744525
[TBL] [Abstract][Full Text] [Related]
14. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
15. Loss and Gain of Natural Killer Cell Receptor Function in an African Hunter-Gatherer Population.
Hilton HG; Norman PJ; Nemat-Gorgani N; Goyos A; Hollenbach JA; Henn BM; Gignoux CR; Guethlein LA; Parham P
PLoS Genet; 2015 Aug; 11(8):e1005439. PubMed ID: 26292085
[TBL] [Abstract][Full Text] [Related]
16. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.
Pittari G; Liu XR; Selvakumar A; Zhao Z; Merino E; Huse M; Chewning JH; Hsu KC; Dupont B
J Immunol; 2013 May; 190(9):4650-60. PubMed ID: 23554313
[TBL] [Abstract][Full Text] [Related]
17. KIR2DS5 in the presence of HLA-C C2 protects against endometriosis.
Nowak I; Płoski R; Barcz E; Dziunycz P; Kamiński P; Kostrzewa G; Milewski Ł; Roszkowski PI; Senitzer D; Malejczyk J; Kuśnierczyk P
Immunogenetics; 2015 Apr; 67(4):203-9. PubMed ID: 25724317
[TBL] [Abstract][Full Text] [Related]
18. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
[TBL] [Abstract][Full Text] [Related]
19. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.
Hiby SE; Apps R; Sharkey AM; Farrell LE; Gardner L; Mulder A; Claas FH; Walker JJ; Redman CW; Morgan L; Tower C; Regan L; Moore GE; Carrington M; Moffett A
J Clin Invest; 2010 Nov; 120(11):4102-10. PubMed ID: 20972337
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT.
Sivori S; Carlomagno S; Falco M; Romeo E; Moretta L; Moretta A
Blood; 2011 Apr; 117(16):4284-92. PubMed ID: 21355085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
